Li H - Search Results

1

Fibroblast growth factor 21 protects against acetaminophen-induced hepatotoxicity by potentiating peroxisome proliferator-activated receptor coactivator protein-1α-mediated antioxidant capacity in mice.

Ye D, Wang Y, Li H, Jia W, Man K, Lo CM, Wang Y, Lam KS, Xu A. Ye D, et al. Among authors: li h. Hepatology. 2014 Sep;60(3):977-89. doi: 10.1002/hep.27060. Epub 2014 Jul 25. Hepatology. 2014. PMID: 24590984

2

Serum fibroblast growth factor 21 is associated with adverse lipid profiles and gamma-glutamyltransferase but not insulin sensitivity in Chinese subjects.

Li H, Bao Y, Xu A, Pan X, Lu J, Wu H, Lu H, Xiang K, Jia W. Li H, et al. J Clin Endocrinol Metab. 2009 Jun;94(6):2151-6. doi: 10.1210/jc.2008-2331. Epub 2009 Mar 24. J Clin Endocrinol Metab. 2009. PMID: 19318452

3

Fibroblast growth factor 21 levels are increased in nonalcoholic fatty liver disease patients and are correlated with hepatic triglyceride.

Li H, Fang Q, Gao F, Fan J, Zhou J, Wang X, Zhang H, Pan X, Bao Y, Xiang K, Xu A, Jia W. Li H, et al. J Hepatol. 2010 Nov;53(5):934-40. doi: 10.1016/j.jhep.2010.05.018. Epub 2010 Jul 17. J Hepatol. 2010. PMID: 20675007

4

Serum levels of osteocalcin are inversely associated with the metabolic syndrome and the severity of coronary artery disease in Chinese men.

Bao Y, Zhou M, Lu Z, Li H, Wang Y, Sun L, Gao M, Wei M, Jia W. Bao Y, et al. Among authors: li h. Clin Endocrinol (Oxf). 2011 Aug;75(2):196-201. doi: 10.1111/j.1365-2265.2011.04065.x. Clin Endocrinol (Oxf). 2011. PMID: 21521333

5

Toll-like receptor-4 mediates obesity-induced non-alcoholic steatohepatitis through activation of X-box binding protein-1 in mice.

Ye D, Li FY, Lam KS, Li H, Jia W, Wang Y, Man K, Lo CM, Li X, Xu A. Ye D, et al. Among authors: li fy, li h, li x. Gut. 2012 Jul;61(7):1058-67. doi: 10.1136/gutjnl-2011-300269. Epub 2012 Jan 17. Gut. 2012. PMID: 22253482

6

Sodium butyrate stimulates expression of fibroblast growth factor 21 in liver by inhibition of histone deacetylase 3.

Li H, Gao Z, Zhang J, Ye X, Xu A, Ye J, Jia W. Li H, et al. Diabetes. 2012 Apr;61(4):797-806. doi: 10.2337/db11-0846. Epub 2012 Feb 14. Diabetes. 2012. PMID: 22338096 Free PMC article.

7

High serum level of fibroblast growth factor 21 is an independent predictor of non-alcoholic fatty liver disease: a 3-year prospective study in China.

Li H, Dong K, Fang Q, Hou X, Zhou M, Bao Y, Xiang K, Xu A, Jia W. Li H, et al. J Hepatol. 2013 Mar;58(3):557-63. doi: 10.1016/j.jhep.2012.10.029. Epub 2012 Nov 7. J Hepatol. 2013. PMID: 23142063

8

Fibroblast growth factor 21: a novel metabolic regulator from pharmacology to physiology.

Li H, Zhang J, Jia W. Li H, et al. Front Med. 2013 Mar;7(1):25-30. doi: 10.1007/s11684-013-0244-8. Epub 2013 Jan 28. Front Med. 2013. PMID: 23358894 Review.

9

Serum fibroblast growth factor 19 levels are decreased in Chinese subjects with impaired fasting glucose and inversely associated with fasting plasma glucose levels.

Fang Q, Li H, Song Q, Yang W, Hou X, Ma X, Lu J, Xu A, Jia W. Fang Q, et al. Among authors: li h. Diabetes Care. 2013 Sep;36(9):2810-4. doi: 10.2337/dc12-1766. Epub 2013 Apr 29. Diabetes Care. 2013. PMID: 23628619 Free PMC article.

10

Mechanism and clinical evidence of lipocalin-2 and adipocyte fatty acid-binding protein linking obesity and atherosclerosis.

Wu G, Li H, Zhou M, Fang Q, Bao Y, Xu A, Jia W. Wu G, et al. Among authors: li h. Diabetes Metab Res Rev. 2014 Sep;30(6):447-56. doi: 10.1002/dmrr.2493. Diabetes Metab Res Rev. 2014. PMID: 24214285 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

122,659 results

Search Page

Filters